-+ 0.00%
-+ 0.00%
-+ 0.00%

Skye Bioscience Publishes Corporate Presentation on Nimacimab–Semaglutide Obesity Combination Strategy

路透·02/22/2026 01:32:30

登錄查看新聞詳情